Andrea Ballabio: "The discovery is the 'magic moment' that any scientist is pursuing."

'Meet' lysosome expert Andrea Ballabio, who will be awarded the 2025 Theodor Bücher medal from FEBS at the 49th FEBS Congress this summer.
Andrea Ballabio: "The discovery is the 'magic moment' that any scientist is pursuing."
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks
Following an MD degree at the University of Naples, Italy, and postdoctoral fellowship at the Institute of Genetics and Biophysics in Naples and at Guy’s hospital in London UK, Andrea Ballabio moved to the USA in 1989 where he was Assistant and then Associate Professor and Co-director of the Human Genome Center at the Department of Molecular and Human Genetics of Baylor College of Medicine in Houston, Texas. In 1994 he became the founding director of the Telethon Institute of Genetics and Medicine (TIGEM) in Italy, and in 1998 he became President of the European Society of Human Genetics. He is currently Professor of Medical Genetics at the University of Naples “Federico II” and Visiting Professor at Baylor College of Medicine in Houston, Texas. He has received three 5-year Advanced Grants of the European Research Council (ERC) and in 2016 won the Louis-Jeantet prize for Medicine. Ballabio is also an Advisory Board Member of INGM Milan, IGBMC Strasbourg, Human Technopole Milan, and VIMM Padua. He is Co-Founder of CASMA Therapeutics and serves as scientific advisor in Next Generation Diagnostics and Avilar Therapeutics. He has been an EMBO member since 1998 and was a former member of the EMBO council. He has authored over 400 publications in international peer-reviewed journals. He obtained the Honorary Titles from the President of Italy of “Commendatore” in 2007 and “Grande Ufficiale” of the Italian Republic in 2021. In 2022 he received the “Laurea Honoris Causa” (honorary title) in Biological Sciences from the University of Camerino. He then won the Feltrinelli Prize in 2021 and subsequently became member of the Accademia dei Lincei in Rome. 

What drew you to your research field?

I wanted to become a paediatrician, so I joined medical school and then took a paediatric residency. While practicing as a paediatrician, I became more and more interested in understanding the basic mechanisms underlying genetic diseases. I was fascinated by the identification of the steps leading from a gene mutation to the biochemical, cellular and physio-pathological defects that cause the disease symptoms. Then I realized that basic biology applied to disease mechanisms was really what I wanted to do, so I left clinical activity and became a basic scientist.

Tell us about one of your favourite published papers from your lab

One of my favourite papers from my lab is: “A gene network regulating lysosomal biogenesis and functionScience 325, 473–477 (2009). In this paper we showed that the function of the lysosome is transcriptionally controlled by TFEB, which is now widely recognized as the master regulator of lysosomal biogenesis and autophagy. This discovery, based primarily on in silico analyses, revealed for the first time that lysosomal genes are co-regulated at the transcriptional level, enabling the lysosomes to behave as dynamic organelles adapting their function to cellular needs.

What’s exciting in your research area right now?

The current focus of my research is on the role of lysosomes in health and disease. In the past few years, many exciting discoveries have been made in this area by several laboratories, including mine. These discoveries changed the view of the lysosome from a trash can that simply collects and recycles the cell waste, to a control centre of cell metabolism. Several signaling pathways have recently been shown to exert their function on the lysosomal surface, thus identifying the lysosome as a signaling hub. In particular, my group is focusing on the mTORC1–TFEB signaling pathway, which allows the lysosome to sense the cell's nutritional status and modulates cell metabolism accordingly. This pathway also plays an important role in cancer cell metabolism.

What aspects of your life as a researcher do you most enjoy?

It is, without any doubt: the DISCOVERY. The discovery is the “magic moment” that any scientist is pursuing. Discovering the “truth”, and being the first to explain it to the world, is one the most exciting feelings that humans can experience. It’s like climbing to the top of the Everest for the first time and telling everybody what the world looks like from there.

What do you look for when selecting students and staff for your research group?

I look for intelligence, curiosity, motivation and perseverance. I do not pay much attention to previous experience and technical abilities.



Lab webpage
: https://www.tigem.it/research/research-faculty/ballabio

Two recent/key papers:

Napolitano, G. et al. (2020) A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome. Nature 585, 597–602. https://doi.org/10.1038/s41586-020-2444-0

Cui, Z. et al. (2023) Structure of the lysosomal mTORC1–TFEB–Rag–Ragulator megacomplex. Nature 614, 572–579. https://doi.org/10.1038/s41586-022-05652-7



More information on the FEBS Theodor Bücher medal and plenary lecture at the 49th FEBS Congress

The Theodor Bücher medal is awarded annually by FEBS for outstanding achievements in Biochemistry and Molecular Biology or related sciences: www.febs.org/other-activities/prizes/febs-medals/

Andrea Ballabio will be presented with the medal at the 49th FEBS Congress in Istanbul, Türkiye on Monday 7th July 2025 where he will deliver a lecture on ‘Lysosomal signaling in metabolic adaptation and tumorigenesis’: 2025.febscongress.org/


Top image of post: by Tumisu from Pixabay

Join the FEBS Network today

Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.